Appropriate payment amounts received on two MyoPro claims; Additional claims are under review
while CMS rulemaking to re-classify the MyoPro to the brace benefit category progresses
BOSTON (August 24, 2023) ─ Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it has received payments for two claims submitted for MyoPro® arm braces provided to Medicare fee-for-service beneficiaries. Read more.